Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia (Q80843267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

title

Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Pek Yee Lum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Yudong D He

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

J Greg Slatter

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Jeffrey F Waring

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Nicollete Zelinsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Guy Cavet

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Xudong Dai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Olivia Fong

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Rebecca Gum

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Lixia Jin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Gary E Adamson

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Christopher J Roberts

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

David B Olsen

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Daria J Hazuda

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

Roger G Ulrich

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

publication date

23 August 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

volume

90

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

464-473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

Discovery of Ritonavir, a Potent Inhibitor of HIV Protease with High Oral Bioavailability and Clinical Efficacy

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Viral dynamics in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Adverse effects of antiretroviral therapy for HIV infection: a review of selected topics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Metabolic and cardiovascular complications of highly active antiretroviral therapy for HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Abnormal fat distribution and use of protease inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Genetic basis of lipodystrophies and management of metabolic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Ritonavir increases the level of active ADD-1/SREBP-1 protein during adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Human immunodeficiency virus protease inhibitors accumulate into cultured human adipocytes and alter expression of adipocytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Ritonavir and dexamethasone induce expression of CYP3A and P-glycoprotein in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Effect of chronic administration of ritonavir on function of cytochrome P450 3A and P-glycoprotein in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Pharmacokinetic enhancement of protease inhibitor therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Pregnane X receptor: molecular basis for species differences in CYP3A induction by xenobiotics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Coordinate transcriptional regulation of transport and metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

The toxicogenomics of nuclear receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

How an inhibitor of the HIV-I protease modulates proteasome activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Atazanavir: a review of its use in the management of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAART.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Cross-talk between nuclear receptors and nuclear factor kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Rodent models for HIV-1 infection and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: effects of rosiglitazone treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YGENO.2007.06.004

10.1016/J.YGENO.2007.06.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17719200 AND SRC:MED&resulttype=core&format=json

3 January 2020

1 reference